Abstract:SYNGAP1 is a high-confidence autism spectrum disorder (ASD) risk gene and mutations in SYNGAP1 lead to a neurodevelopmental disorder (NDD) that presents with epilepsy, ASD, motor developmental delay, and intellectual disability. SYNGAP1 codes for Ras/Rap GTP-ase activating protein SynGAP (SynGAP). In mice, SynGAP is located in the postsynaptic density of glutamatergic synapses and regulates glutamate receptor trafficking in an activity-dependent manner. In addition to forebrain glutamatergic neurons, Syngap1 is highly expressed in the striatum, although the functions of SynGAP in the striatum have not been extensively studied. Here we show that Syngap1 is expressed in both direct and indirect pathway striatal projection neurons (dSPNs and iSPNs) in mice of both sexes. In a mouse model of Syngap1 haploinsufficiency, dendritic spine density, morphology, and intrinsic excitability are altered primarily in iSPNs, but not dSPNs. At the behavioral level, SynGAP reduction alters striatal-dependent motor learning and goal-directed behavior. Several behavioral phenotypes are reproduced by iSPN-specific Syngap1 reduction and, in turn, prevented by iSPN-specific Syngap1 rescue. These results establish the importance of SynGAP to striatal neuron function and pinpoint the indirect pathway as a key circuit in the neurobiology of SYNGAP1-related NDD.Significance statement SYNGAP1 mutations cause a neurodevelopmental disorder presenting with intellectual disability, motor problems, epilepsy, autism spectrum disorder, and a constellation of other behavioral and psychiatric conditions. SynGAP protein is highly expressed in the striatum but its functions in this brain region have not yet been explored. This study shows that loss of one copy of the Syngap1 gene from striatal indirect, but not direct, pathway neurons alters synaptic properties, cellular excitability, motor behaviors, and goal-directed responding in mice. This work provides a new perspective on the functions of SynGAP and suggests that altered activity in striatal circuits may be an important driver of the motor and learning alterations in people with SYNGAP1 disorder.

Atomistic simulations reveal impacts of missense mutations on the structure and function of SynGAP1

Using Structural Analysis to Clarify the Impact of Single Nucleotide Variants in Neurexin/neuroligin Revealed in Clinical Genomic Sequencing

Molecular dynamics simulations reveal molecular mechanisms for the gain and loss of function effects of four variants

Hyperexcitability and translational phenotypes in a preclinical mouse model of SYNGAP1- related intellectual disability

In silico analysis of alpha‐synuclein protein variants and posttranslational modifications related to Parkinson's disease

A de novo missense mutation in synaptotagmin-1 associated with neurodevelopmental disorder desynchronizes neurotransmitter release

Pathogenicity Prediction of GABAA Receptor Missense Variants

Human SYNGAP1 Regulates the Development of Neuronal Activity by Controlling Dendritic and Synaptic Maturation

Dynamic coupling of residues within proteins as a mechanistic foundation of many enigmatic pathogenic missense variants

Structural analysis of pathogenic missense mutations in GABRA2 and identification of a novel de novo variant in the desensitization gate

Haploinsufficiency of Syngap1 in striatal indirect pathway neurons alters motor and goal-directed behaviors in mice

Presynaptic hyperexcitability reversed by positive allosteric modulation of a GABABR epilepsy variant

Interaction networks within disease-associated GαS variants characterized by an integrative biophysical approach

Molecular Modelling of nsSNPs in GABRA2 Gene in Epilepsy and Study of Their Impact On Structure and Stability of GABRA2 Protein

Comprehensive in silico analysis and molecular dynamics of the superoxide dismutase 1 (SOD1) variants related to amyotrophic lateral sclerosis

Mutations in Glycosyltransferases and Glycosidases: Implications for Associated Diseases

Reduced protein stability of 11 pathogenic missense STXBP1/MUNC18-1 variants and improved disease prediction

Comprehensive mapping of mutations in TDP-43 and α-Synuclein that affect stability and binding

Key roles of C2/GAP domains in SYNGAP1-related pathophysiology

Study of the Uncertainly Significant Variants reveal major Structural, Functional fluctuations leading to potential Disease-Based Associations